RFID Technology to be Used in Next Generation Breast Implant for Better Health and Safety
Since breast implant patients are frequently advised to have their breast implants removed or expect them to be replaced every 10 to 15 years, a medical technology start-up is on a mission is to make breast implants safer and better for women globally. The Costa Rica-based company plans to do this by delivering a world class technology platform that promotes women’s health and enables the strategic adoption of Motiva as the brand of choice in the market,” said Juan José Chacón-Quirós, CEO of Establishment Labs. “The investment and partnership from Crown Predator and JW Asset Management and the global relationships and experience they provide will enable us to accelerate investment in our technology, grow our customer base, and scale our business to meet growing demand. We are excited to officially begin the journey to bring our next generation Motiva implants to the United States, the largest market for breast aesthetics in the world.”
Establishment Labs is a global, privately held, aesthetic company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants.
Today, thousands of patients and plastic surgeons in over 50 countries and across five continents are choosing Motiva implants that include exclusive capabilities like RFID microtransponders, fully biocompatible nanosurfaces, and TrueTissue™ dynamics for the look and feel of natural breasts, and an extended product guarantee through Lloyd’s of London. Motiva implants have reported complication rates of less than 1% after 5 years of implantation. That RFID technology, aka VeriTeQ, is reported as the first FDA-cleared microtransponder for use in humans. It is also the only one with a CE mark for breast implant use, the company has stated. The company reports complication rates of less than 1% after 5 years of implantation.
“We see tremendous opportunities in the breast aesthetics market. After spending significant time analyzing the space and meeting with leading plastic surgeons, we found Motiva to be the leading technology brand that meets the demands of health-conscious women worldwide”, said Nick Lewin, Managing Partner at Crown Predator Holdings. “Women deserve to have the best minds, both doctors and scientists, working on breast implant technology, and have a product that incorporates all the advancements in medical devices, surface technology, and silicon innovation over the past 25 years.
Jason Wild, President and Chief Investment Officer at JW Asset Management added, “The team at Establishment Labs is focused on delivering the highest quality products in the industry, including an advanced technology platform to provide a first class customer experience. Establishment Labs is poised to become a market leader in breast aesthetics and we are excited to be a part of this round of financing.”